FY2025 EPS Estimates for Bruker Co. (NASDAQ:BRKR) Decreased by Analyst

Bruker Co. (NASDAQ:BRKR) – Zacks Research reduced their FY2025 earnings estimates for shares of Bruker in a note issued to investors on Wednesday, September 18th. Zacks Research analyst R. Department now forecasts that the medical research company will earn $3.07 per share for the year, down from their prior forecast of $3.09. The consensus estimate for Bruker’s current full-year earnings is $2.61 per share. Zacks Research also issued estimates for Bruker’s FY2026 earnings at $3.64 EPS.

Bruker (NASDAQ:BRKR) last issued its quarterly earnings results on Tuesday, August 6th. The medical research company reported $0.52 EPS for the quarter, meeting analysts’ consensus estimates of $0.52. The firm had revenue of $800.70 million for the quarter, compared to analysts’ expectations of $799.44 million. Bruker had a return on equity of 24.92% and a net margin of 11.29%. The business’s revenue for the quarter was up 17.4% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.50 EPS.

A number of other research analysts have also recently commented on BRKR. Citigroup lowered their target price on Bruker from $95.00 to $80.00 and set a “buy” rating for the company in a research note on Wednesday, July 10th. The Goldman Sachs Group cut their target price on Bruker from $72.00 to $60.00 and set a “sell” rating on the stock in a research note on Tuesday, July 9th. TD Cowen reduced their price target on Bruker from $74.00 to $72.00 and set a “hold” rating for the company in a research report on Wednesday, August 7th. Wells Fargo & Company began coverage on shares of Bruker in a report on Tuesday, August 27th. They issued an “overweight” rating and a $78.00 target price for the company. Finally, Jefferies Financial Group began coverage on shares of Bruker in a research note on Monday, June 3rd. They set a “buy” rating and a $85.00 price target for the company. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and seven have issued a buy rating to the company’s stock. According to data from MarketBeat.com, Bruker presently has an average rating of “Moderate Buy” and an average target price of $81.40.

Bruker Stock Down 1.1 %

BRKR opened at $67.54 on Friday. The business’s fifty day simple moving average is $64.56 and its 200 day simple moving average is $72.76. The stock has a market cap of $9.82 billion, a PE ratio of 24.56, a P/E/G ratio of 2.31 and a beta of 1.18. Bruker has a 52 week low of $53.79 and a 52 week high of $94.86. The company has a quick ratio of 0.75, a current ratio of 1.65 and a debt-to-equity ratio of 1.18.

Institutional Investors Weigh In On Bruker

Several hedge funds have recently bought and sold shares of the stock. Norges Bank purchased a new stake in Bruker in the 4th quarter worth $74,582,000. Marshall Wace LLP increased its holdings in shares of Bruker by 127.8% in the second quarter. Marshall Wace LLP now owns 1,389,537 shares of the medical research company’s stock valued at $88,666,000 after purchasing an additional 779,549 shares during the last quarter. Point72 Asset Management L.P. purchased a new stake in shares of Bruker in the second quarter valued at about $36,472,000. TD Asset Management Inc lifted its holdings in Bruker by 51.1% in the fourth quarter. TD Asset Management Inc now owns 1,664,779 shares of the medical research company’s stock valued at $122,328,000 after acquiring an additional 562,684 shares during the last quarter. Finally, Public Employees Retirement Association of Colorado lifted its position in Bruker by 925.8% in the fourth quarter. Public Employees Retirement Association of Colorado now owns 362,035 shares of the medical research company’s stock valued at $26,602,000 after buying an additional 326,741 shares during the last quarter. Hedge funds and other institutional investors own 79.52% of the company’s stock.

Bruker Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, September 16th. Investors of record on Monday, September 2nd were issued a dividend of $0.05 per share. This represents a $0.20 annualized dividend and a yield of 0.30%. The ex-dividend date was Friday, August 30th. Bruker’s dividend payout ratio (DPR) is 7.27%.

About Bruker

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.